T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Discretionary | 15.13% |
| 3 | Financials | 13.68% |
| 4 | Technology | 12.92% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
AXIS Capital
AXS
$7.37B
| $3.05M | ﹤0.01% |
54,953
+15,648
| +40% | +$846K |
|
|
EV
1452
DELISTED
Eaton Vance Corp.
EV
| $3.04M | ﹤0.01% |
90,710
+4,200
| +5% | +$125K |
|
|
ICPT
1453
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.03M | ﹤0.01% |
23,585
-314,171
| -93% | -$37.1M |
|
1454
Lear
LEA
$8.24B
| $2.96M | ﹤0.01% |
26,623
+3,363
| +14% | +$356K |
|
1455
National Fuel Gas
NFG
$7.75B
| $2.96M | ﹤0.01% |
59,081
+25,315
| +75% | +$1.17M |
|
|
VER
1456
DELISTED
VEREIT, Inc.
VER
| $2.93M | ﹤0.01% |
66,003
+6,325
| +11% | +$251K |
|
1457
SiriusXM
SIRI
$9.53B
| $2.91M | ﹤0.01% |
73,742
+5,949
| +9% | +$222K |
|
1458
UGI
UGI
$7.57B
| $2.9M | ﹤0.01% |
72,071
+6,180
| +9% | +$224K |
|
|
FSYS
1459
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $2.88M | ﹤0.01% |
520,780
+1,120
| +0.2% | +$5.13K |
|
1460
HF Sinclair
DINO
$16.5B
| $2.83M | ﹤0.01% |
80,246
+7,820
| +11% | +$269K |
|
|
Y
1461
DELISTED
Alleghany Corp
Y
| $2.83M | ﹤0.01% |
5,693
+1,084
| +24% | +$513K |
|
|
FLG
1462
Flagstar Bank National Association
FLG
$5.92B
| $2.73M | ﹤0.01% |
57,160
+2,500
| +5% | +$116K |
|
1463
Wolfspeed
WOLF
$1.59B
| $2.71M | ﹤0.01% |
93,081
+33,318
| +56% | +$955K |
|
|
BNFT
1464
DELISTED
Benefitfocus, Inc.
BNFT
| $2.7M | ﹤0.01% |
81,012
-73,264
| -47% | -$2.18M |
|
|
WFT
1465
DELISTED
Weatherford International plc
WFT
| $2.69M | ﹤0.01% |
345,125
+95,950
| +39% | +$647K |
|
|
PZN
1466
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.68M | ﹤0.01% |
354,900
-5,600
| -2% | -$39.3K |
|
1467
Annaly Capital Management
NLY
$17.6B
| $2.67M | ﹤0.01% |
65,158
+6,905
| +12% | +$271K |
|
|
HMHC
1468
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2.66M | ﹤0.01% |
133,500
+40,600
| +44% | +$747K |
|
|
AGTC
1469
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.66M | ﹤0.01% |
189,981
| – | – |
|
1470
ICICI Bank
IBN
$106B
| $2.64M | ﹤0.01% |
405,829
+38,385
| +10% | +$225K |
|
|
WPG
1471
DELISTED
Washington Prime Group Inc.
WPG
| $2.63M | ﹤0.01% |
30,794
-348,228
| -92% | -$28.3M |
|
1472
NVR
NVR
$16.9B
| $2.62M | ﹤0.01% |
1,512
+130
| +9% | +$210K |
|
|
WBT
1473
DELISTED
Welbilt, Inc.
WBT
| $2.62M | ﹤0.01% |
+177,503
| New | +$2.58M |
|
1474
Arthur J. Gallagher & Co
AJG
$64.5B
| $2.61M | ﹤0.01% |
58,741
+8,240
| +16% | +$329K |
|
1475
Cheniere Energy
LNG
$55.8B
| $2.57M | ﹤0.01% |
75,850
+4,757
| +7% | +$154K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.